Original Query: ALL
Previous Study | Return to List | Next Study

AFP- L3% and DCP as Tumor Markers in Patients With Hepatocellular Carcinoma (HCC) Treated With Transarterial Chemoembolisation (TACE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01360255
Recruitment Status : Unknown
Verified December 2011 by Dominik Bettinger, University Hospital Freiburg.
Recruitment status was:  Recruiting
First Posted : May 25, 2011
Last Update Posted : December 15, 2011
Wako Diagnostics
Information provided by (Responsible Party):
Dominik Bettinger, University Hospital Freiburg

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : December 2011
  Estimated Study Completion Date : December 2011